NHS to pioneer a twice-a-year injection that reduces bad cholesterol
Kathmandu, January 14
National Health Service in England is set to pioneer a twice-a-year injection that reduces bad cholesterol to protect the heart.
Although, millions of people take daily statin pills to cut their cholesterol, but later this year, a "ground-breaking" large-scale clinical trial will offer NHS patients a new form of medicine, gene silencing, in an injection called inclisiran, as reported by the BBC.
England's Health Secretary Matt Hancock said the initiative could save 30,000 lives during the next decade.
Actually, cholesterol is a fatty substance in the blood, produced by the liver, which can build up inside the walls of blood vessels, making them narrower and increasing the risk of having a heart attack or stroke.
Through, silencing the PCSK9 gene, inclisiran help the liver absorb more bad cholesterol from the blood and break it down.
Officials informed that the trials presented at the European Society of Cardiology last year showed it could cut bad cholesterol levels in half within weeks.
The Department of Health and Social Care said it would prevent 55,000 heart attacks and strokes each year for every 300,000 patients treated.
